Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E PROTEIN KINASE INHIBITORS
L01EM Phosphatidylinositol-3-kinase (Pi3K) inhibitors
L01EM04 Duvelisib
D11658 Duvelisib hydrate (JAN) <US>
Drug groups [BR:br08330]
Antineoplastic
DG03139 PI3K inhibitor
DG03073 Duvelisib
D11658 Duvelisib hydrate
Target-based classification of drugs [BR:br08310]
Enzymes
Transferases (EC2)
Phosphotransferase
PIK3CD
D11658 Duvelisib hydrate (JAN) <US>
PIK3CG
D11658 Duvelisib hydrate (JAN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11658
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D11658
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11658
Drug groups [BR:br08330]
Antineoplastic
DG03139 PI3K inhibitor
DG03073 Duvelisib